News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
143 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17781)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
FDA
Exelixis Announces U.S. FDA Approval of CABOMETYX (cabozantinib) Tablets for Previously Untreated Advanced Renal Cell Carcinoma
RCC is the most common form of kidney cancer in adults.
December 19, 2017
·
16 min read
Epigenomics AG gets CE-IVD Mark for Lung Cancer Test Epi proLung
Epi proLung is a highly innovative lung cancer test based on the combination of Epigenomics’ proprietary DNA methylation biomarkers.
December 19, 2017
·
1 min read
Major Changes for Bio Supply Forecast in 2018 by bioLIVE
Industry experts from bioLIVE - the new UBM biomanufacturing and bioprocessing event taking place next year in Madrid - predict that 2018 will usher in a new age of increased integration and collaboration across the large and small molecule supply chain.
December 19, 2017
·
3 min read
Biotech Bay
PREMIER Biosoft Announces the Release of SimGlycan 5.90 Offering Faster and More Accurate Search Results, Enabling Glycomics Research
The new version is about five times faster than the last version and allows for more accurate glycan identification with the updated algorithms.
December 19, 2017
·
1 min read
Biotech Bay
Agilent Receives Multiple Innovation Awards From The Analytical Scientist
Awards from The Analytical Scientist highlight innovations delivered by transformative technology
December 19, 2017
·
3 min read
Xenex: Ochsner Medical Center Reports 49% Decrease in Infection Rates After Germ-Fighting Robots Deployed to Disinfect Patient Rooms
Recognizing the growing threat of antibiotic resistance and superbugs, Ochsner Medical Center - Jefferson Highway recently deployed a fleet of Xenex LightStrike Germ-Zapping Robots, which is yielding substantial results.
December 19, 2017
·
2 min read
Business
Hikma Reaches Licensing Agreement With Celltrion for Third Biosimilar Product in the Middle East and North Africa
Hikma now has exclusive agreements with Celltrion for three biosimilar products - Truxima, Remsima and Herzuma - in all its MENA markets.
December 19, 2017
·
1 min read
Business
Innoviva and Sarissa Implement Court Order
Innoviva announced it implemented the Delaware Court of Chancery’s order enforcing the oral settlement agreement with Sarissa Capital Domestic Fund LP and certain of its affiliates (together, “Sarissa”) in connection with the Company’s 2017 annual meeting of stockholders
December 19, 2017
·
6 min read
Business
SoCal Biotech Inks Pact With Biogen For Spinal Muscular Atrophy Drug Development
Biogen will have the option to license therapies arising out of this collaboration and will be responsible for their development and commercialization.
December 19, 2017
·
9 min read
Policy
U.S. FDA Approves Pfizer’s BOSULIF (bosutinib) for the Treatment of Patients with Newly-Diagnosed Ph+ Chronic Myelogenous Leukemia (CML)
The sNDA was reviewed and approved under the FDA’s Priority Review and accelerated approval programs based on molecular and cytogenetic response rates.
December 19, 2017
·
13 min read
Previous
10 of 15
Next